Compare ETFs: SURI
SURI
Comparison
Average Return
Symbol | Year-to-date | 1 Year | 5 Years | 10 Years | Inception |
---|---|---|---|---|---|
SURI | 9.76% | -15.66% | - | - | -3.25% |
Top 25 Holdings
SURI - Simplify Propel Opportunities ETF | |||
---|---|---|---|
No. | Symbol | Name | Weight |
1 | PAGP | Plains GP Holdings, L.P. | 36.34% |
2 | Cash | Cash | 17.82% |
3 | AKRO | Akero Therapeutics, Inc. | 12.07% |
4 | PHAT | Phathom Pharmaceuticals, Inc. | 7.34% |
5 | ABEO | Abeona Therapeutics Inc. | 4.85% |
6 | TELSAT.6.5 10.15.27 144A | TELSAT 6.5 10/15/27 144A Corp | 3.50% |
7 | MIST | Milestone Pharmaceuticals Inc. | 2.83% |
8 | APLT | Applied Therapeutics, Inc. | 2.51% |
9 | TELSAT.5.625 12.06.26 144A | TELSAT 5.625 12/06/26 144A Corp | 2.39% |
10 | TCRX | TScan Therapeutics, Inc. | 2.28% |
11 | DCTH | Delcath Systems, Inc. | 2.21% |
12 | ZVRA | Zevra Therapeutics, Inc. | 2.01% |
13 | ACHV | Achieve Life Sciences, Inc. | 1.13% |
14 | EPA: MAAT | MaaT Pharma SA | 0.83% |
15 | ATHA | Athira Pharma, Inc. | 0.67% |
16 | EIGRQ | Eiger BioPharmaceuticals, Inc. | 0.62% |
17 | CAPR | Capricor Therapeutics, Inc. | 0.60% |
18 | n/a | CONTRA CHINOOK THERAPE + NPV | 0.00% |
19 | n/a | n/a | n/a |
20 | n/a | n/a | n/a |
21 | n/a | n/a | n/a |
22 | n/a | n/a | n/a |
23 | n/a | n/a | n/a |
24 | n/a | n/a | n/a |
25 | n/a | n/a | n/a |
View SURI holdings |